Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2 (COVID-19) Severe Pneumonia”

662 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 662 results

Not applicableUnknownNCT04904523
What this trial is testing

Blood Markers for Identifying & Investigating Infection With COVID19 & Sepsis in Children.

Who this might be right for
Covid19Sepsis
Cardiff University 300
Post-approval studies (Phase 4)Study completedNCT04969250
What this trial is testing

Vaccination for Recovered Inpatients With COVID-19 (VATICO)

Who this might be right for
Covid19
National Institute of Allergy and Infectious Diseases (NIAID) 66
Not applicableStudy completedNCT04681001
What this trial is testing

Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers

Who this might be right for
Respiratory Viral InfectionCommon ColdSevere Acute Respiratory Syndrome (SARS) Pneumonia+2 more
Marinomed Biotech AG 300
Testing effectiveness (Phase 2)Study completedNCT04354870
What this trial is testing

COVID-19 PrEP HCW HCQ Study

Who this might be right for
COVID-19
NYU Langone Health 130
Not applicableStudy completedNCT05289141
What this trial is testing

Interest in the Use of Nasal High-Flow Oxygen Therapy (OptiFlow™) in Secondary Transport of COVID-19 Positive Patients

Who this might be right for
COVID-19
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 229
Testing effectiveness (Phase 2)WithdrawnNCT05545319
What this trial is testing

Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Coronavirus Disease 2019 (COVID-19)Immunocompromised+2 more
Pfizer
Not applicableWithdrawnNCT04878042
What this trial is testing

COVID-19 Infection Control Using H2O2 Mouth Wash and Nasal Spray

Who this might be right for
COVID-19
EPISTATA
Testing effectiveness (Phase 2)UnknownNCT05200754
What this trial is testing

Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19

Who this might be right for
SARS-CoV-2 Infection
Carsten Müller-Tidow 174
Testing effectiveness (Phase 2)Study completedNCT04342650
What this trial is testing

Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection

Who this might be right for
COVID-19SARS-CoV InfectionSevere Acute Respiratory Syndrome (SARS) Pneumonia+1 more
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado 152
Large-scale testing (Phase 3)Study completedNCT04518410
What this trial is testing

ACTIV-2: A Study for Outpatients With COVID-19

Who this might be right for
CoronavirusCovid19
National Institute of Allergy and Infectious Diseases (NIAID) 4,044
Post-approval studies (Phase 4)Study completedNCT04340557
What this trial is testing

Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection

Who this might be right for
SARS-CoV Infection
Sharp HealthCare 31
Not applicableStudy completedNCT04396353
What this trial is testing

EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes in Patients With COVID-19

Who this might be right for
COVID-19SARS-CoV 2Corona Virus Infection+1 more
University of Sao Paulo General Hospital 1,574
Not applicableStudy completedNCT05439044
What this trial is testing

A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB)

Who this might be right for
Immunocompromised Patients
Assistance Publique - Hôpitaux de Paris 4,235
Large-scale testing (Phase 3)Study completedNCT04611802
What this trial is testing

Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 33,000
Not applicableUnknownNCT04490473
What this trial is testing

Turkish of the SARS-CoV-2 Anxiety Scale

Who this might be right for
AnxietySARS-CoV Infection
DILEK SAYIK 300
Early research (Phase 1)Study completedNCT05220605
What this trial is testing

Nebulised BromAc in Healthy Volunteers

Who this might be right for
COVID-19 PneumoniaBromelains Adverse ReactionAcetylcysteine Adverse Reaction+2 more
Mucpharm Pty Ltd 12
Not applicableUnknownNCT05036941
What this trial is testing

A Trial of Two Mask Systems in Preventing SARS CoV-2 in Healthcare Workers (HCW)

Who this might be right for
SARS CoV-2 InfectionInfluenza -Like Illness
Ascend Performance Materials 1,600
Testing effectiveness (Phase 2)WithdrawnNCT04561180
What this trial is testing

Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Evergreen Therapeutics, Inc.
Not applicableEnded earlyNCT05012280
What this trial is testing

Malaria as a Protection Factor Against Severe COVID-19 (Known as SARS-COV-2) in the Democratic Republic of Congo (Palu-COVID)

Who this might be right for
Covid19Paludism
Institute of Tropical Medicine, Belgium 238
Large-scale testing (Phase 3)WithdrawnNCT05157269
What this trial is testing

Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness

Who this might be right for
COVID-19
Romark Laboratories L.C.
Load More Results